Glofitamab

Glofitamab
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T76685-1mg 1 mg -

7 - 10 business days*

468.00€
TGM-T76685-5mg 5 mg -

7 - 10 business days*

1,363.00€
TGM-T76685-10mg 10 mg -

7 - 10 business days*

2,237.00€
 
Description: Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T... more
Product information "Glofitamab"
Description: Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas. Target: Others. References: Bröske AE, et al. Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma. Blood Adv. 2022,6(3):1025-1037.
Keywords: CD20-TCB, RG 6026, RO7082859
Supplier: TargetMol
Supplier-Nr: T76685

Properties

Application: Targets B-lymphocyte antigen CD20 (MS4A1, CD20)
Conjugate: No

Database Information

CAS : 2229047-91-8| Matching products
KEGG ID : K06451 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Glofitamab"
Write a review
or to review a product.
Viewed